Found 75 matching trials
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma N/A Hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Show More Location
Chinese PLA General hospital
Learn More & Join Trial
Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC PHASE2 This is a prospective, open-label, single-center clinical study, to evaluat...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System. PHASE2 This is a single-arm, open, Phase II clinical study of Tislelizumab combine...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma PHASE3 Cholangiocarcinoma (CCA) is a heterogeneous group of cancers arising from t...
Show More Location
The Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Randomized Controlled Trial Evaluating Different Doses of Oral Zinc Supplementation in Combination With Targeted Immunotherapy for Unresectable or Advanced Hepatocellular Carcinoma PHASE2 This study will look at whether adding daily oral zinc supplements to targe...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Learn More & Join Trial
Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) PHASE2 This study will evaluate the efficacy and safety of cryoablation combined w...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC N/A Combination treatment with antiangiogenic agents and anti-programmed cell d...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
HAIC+Lenvatinib+Tislelizumab vs D-TACE+Lenvatinib+Tislelizumab for Unresectable HCC PHASE2 Drug-eluting Bead-Transarterial chemoembolization (D-TACE) is the most wide...
Show More Location
The Second Affiliated Hospital of Nanchang University
Learn More & Join Trial
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of hepatic...
Show More Status
Active Not Recruiting
Location
The first hospital of China medical university
Learn More & Join Trial